Home / Research projects / POST-DURV "Observational study on treatment strategies in clinical practice in patients with stage III NSCLC progressing to consolidation therapy with Durvalumab"
Share
POST-DURV "Observational study on treatment strategies in clinical practice in patients with stage III NSCLC progressing to consolidation therapy with Durvalumab"
Project objectives
This is a retrospective-prospective multicenter observational study of patients with NSCLC progressing on consolidation therapy with durvalumab.
The retrospective-prospective study design involves both a primary collection of data during the enrollment visit and the follow-up visit, and a secondary collection of data during the retrospective observation period. The primary objective of the study is the description of therapeutic strategies in patients who present clinical-radiological progression to consolidation therapy with durvalumab.
Start and end date
November 23, 2020 - In progress
Project Manager
Sara Ramella - Principal Investigator
Coordinating institution of the project
Pulmonary Oncology-Department of Oncology-University of Turin, AOU San Luigi, Orbassano
Other Institutions involved
AOU Parma (Dr.Alessandro Leonetti)
AOU Careggi-Florence (Dr. Vieri Scotti)
National Cancer Institute IRCCS Pascale Napoli (Dr. Alessandro Morabito)
San Camillo Hospital-Rome (Dr. Maria Rita Migliorino)
Regina Elena National Institute (Dr. Fabiana Cecere-Oncology A)
Milan Polyclinic (Dr. Francesco Grossi)
AO San Gerardo Monza (Dr. Diego Cortinovis)
Humanitas Gavezzeni-Bergamo (Dr. Giovanni Luca Ceresoli)